Stockscreener 앱 받기
30.83
4.11%
-1.32
시간 외 거래:
30.81
-0.02
-0.06%
전일 마감가:
$32.15
열려 있는:
$32.04
하루 거래량:
290.83K
Relative Volume:
0.73
시가총액:
$578.88M
수익:
-
순이익/손실:
$-74.15M
주가수익비율:
-7.6291
EPS:
-4.0411
순현금흐름:
$-60.29M
1주 성능:
-9.64%
1개월 성능:
+46.81%
6개월 성능:
+105.81%
1년 성능:
+40.65%
1일 변동 폭
$30.77
$32.46
1주일 범위
$30.69
$34.68
52주 변동 폭
$13.70
$36.03
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
30.83 | 603.67M | 0 | -74.15M | -60.29M | -4.0411 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-09-03 | 개시 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-21 | 개시 | Mizuho | Outperform |
| 2024-11-20 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | TD Cowen | Buy |
| 2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2019-04-05 | 개시 | Janney | Buy |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-17 | 개시 | H.C. Wainwright | Buy |
| 2018-07-16 | 개시 | Wedbush | Outperform |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Buybacks Report: Is Tectonic Therapeutic Inc stock forming a cup and handle2026 Technicals & Proven Capital Preservation Methods - baoquankhu1.vn
Layoff Watch: What is the next catalyst for Pasithea Therapeutics Corp Equity WarrantQuarterly Market Review & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Gains Report: What are analysts price targets for Tectonic Therapeutic Inc2026 Intraday Action & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Aug Action: Does Tectonic Therapeutic Inc outperform in volatile markets2026 PostEarnings & Stepwise Trade Signal Guides - baoquankhu1.vn
Farallon Capital Management LLC Cuts Stock Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
First Light Asset Management LLC Makes New $3.18 Million Investment in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Braidwell LP Makes New $11.56 Million Investment in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Prosight Management LP Has $5.95 Million Stock Holdings in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Gains Report: Can Tectonic Therapeutic Inc outperform under higher oil prices2026 Gainers & Long-Term Capital Growth Strategies - baoquankhu1.vn
Tectonic Therapeutic (TECX) to Release Earnings on Thursday - MarketBeat
TECX: TX45 and TX2100 advance in key indications, with pivotal data expected by early 2027 - TradingView
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Marcella Ruddy Sells Shares of Tectonic Therapeuti - GuruFocus
Peter Mcnamara Sells 6,262 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 10,000 Shares of Stock - MarketBeat
Tectonic Therapeutic (TECX) CMO sells 10,000 shares in Rule 10b5-1 plan - Stock Titan
Tectonic Therapeutic (TECX) CSO sells shares after exercising options - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 9.8%Should You Sell? - MarketBeat
Stocks showing market leadership: Tectonic Therapeutic earns 96 RS rating - MSN
Published on: 2026-03-08 21:54:41 - baoquankhu1.vn
Aug Breakouts: Can Tectonic Therapeutic Inc. lead its sector in growthMarket Activity Recap & Community Driven Trade Alerts - baoquankhu1.vn
Published on: 2026-03-07 08:33:07 - baoquankhu1.vn
Unveiling Bumps: How Tectonic Therapeutic’s Recent Moves Affect the Market - timothysykes.com
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Peter Mcnamara Sells 1,650 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,649 Shares of Stock - MarketBeat
Tectonic Therapeutic (TECX) CEO receives option and RSU equity grants - Stock Titan
Tectonic Therapeutic (TECX) grants options and RSUs to CBO - Stock Titan
Tectonic Therapeutic (TECX) CMO receives RSU and stock option awards - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month HighHere's Why - MarketBeat
TECX SEC FilingsTectonic Therapeutic Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 11.4%What's Next? - MarketBeat
Tectonic Therapeutic to Participate in March Investor Conferences - Bitget
Quarterly Risk: Is Tectonic Therapeutic Inc stock forming a cup and handleJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - baoquankhu1.vn
TECX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Promising Biotech with a Potential 227% Upside - DirectorsTalk Interviews
Chen Yu and TCG report 6.2% stake in Tectonic Therapeutic (NASDAQ: TECX) - Stock Titan
Tectonic Therapeutics' Q4 Net Loss Widens; Phase 2 APEX Trial Data Due In 2026 - Nasdaq
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and BioLife Solutions (BLFS) - The Globe and Mail
TECX: Strong cash position and advancing clinical pipeline, with key trial results expected in 2026 - TradingView
Tectonic Therapeutic, Inc. Reports Positive Phase 1b Results for TX45 in Pulmonary Hypertension and Advances TX2100 into Phase 1a Trial for Hereditary Hemorrhagic Telangiectasia - Quiver Quantitative
TECXForm 8-KCurrent report - ADVFN Ltd
Tectonic Therapeutic, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic drug cuts heart-lung pressure 29%, backed by cash into 2028 - Stock Titan
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins - MarketBeat
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) - The Globe and Mail
Tectonic Therapeutic Announces Leadership Transition and New Chair - TipRanks
Insider Trends: Is now the right time to enter Tectonic Therapeutic IncDollar Strength & Daily Entry Point Alerts - baoquankhu1.vn
Tectonic Therapeutic Inc (TECX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):